Drug Profile
Alkasar 18
Alternative Names: N4-octadecyl-ara-C; NOACLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator University Hospital Zurich
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer